PL2343052T3 - Hydrophilic filtration during manufacture of vaccine adjuvants - Google Patents
Hydrophilic filtration during manufacture of vaccine adjuvantsInfo
- Publication number
- PL2343052T3 PL2343052T3 PL10252044T PL10252044T PL2343052T3 PL 2343052 T3 PL2343052 T3 PL 2343052T3 PL 10252044 T PL10252044 T PL 10252044T PL 10252044 T PL10252044 T PL 10252044T PL 2343052 T3 PL2343052 T3 PL 2343052T3
- Authority
- PL
- Poland
- Prior art keywords
- during manufacture
- vaccine adjuvants
- filtration during
- hydrophilic filtration
- hydrophilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
- B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
- B01F27/271—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator
- B01F27/2711—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator provided with intermeshing elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/80—Mixing plants; Combinations of mixers
- B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
- B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28351709P | 2009-12-03 | 2009-12-03 | |
EP10252044.2A EP2343052B1 (en) | 2009-12-03 | 2010-12-03 | Hydrophilic filtration during manufacture of vaccine adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2343052T3 true PL2343052T3 (en) | 2013-11-29 |
Family
ID=43971135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10252044T PL2343052T3 (en) | 2009-12-03 | 2010-12-03 | Hydrophilic filtration during manufacture of vaccine adjuvants |
Country Status (22)
Country | Link |
---|---|
US (3) | US10213383B2 (en) |
EP (3) | EP2601933B1 (en) |
JP (2) | JP5754860B2 (en) |
KR (2) | KR101616735B1 (en) |
CN (2) | CN104688687A (en) |
AU (1) | AU2010325748B2 (en) |
BR (1) | BR112012013425A2 (en) |
CA (1) | CA2780425C (en) |
CL (1) | CL2012001268A1 (en) |
DK (1) | DK2343052T3 (en) |
EA (1) | EA025622B1 (en) |
ES (3) | ES2558056T3 (en) |
HK (2) | HK1159995A1 (en) |
HR (1) | HRP20130623T1 (en) |
IL (1) | IL219627B (en) |
MX (1) | MX2012005598A (en) |
NZ (1) | NZ599881A (en) |
PL (1) | PL2343052T3 (en) |
PT (1) | PT2343052E (en) |
SG (1) | SG10201501612RA (en) |
SI (2) | SI2601933T1 (en) |
WO (1) | WO2011067669A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2012001399A1 (en) | 2009-12-03 | 2013-03-08 | Novartis Ag | Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion. |
CN105055311A (en) | 2009-12-03 | 2015-11-18 | 诺华股份有限公司 | Circulation of components during homogenization /microfluidisation of emulsions |
DE102009056884B4 (en) | 2009-12-03 | 2021-03-18 | Novartis Ag | Vaccine Adjuvants and Improved Methods for Making Same |
MX2012005598A (en) | 2009-12-03 | 2012-05-29 | Novartis Ag | Hydrophilic filtration during manufacture of vaccine adjuvants. |
EP2506833B1 (en) † | 2009-12-03 | 2014-04-16 | Novartis AG | Arranging interaction and back pressure chambers for microfluidization |
PT3103784T (en) | 2010-05-12 | 2019-05-20 | Novartis Ag | Manufacture of an oil-in-water emulsion comprising squalene |
GB201009676D0 (en) | 2010-06-10 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel process |
BR112013024976A2 (en) * | 2011-03-30 | 2016-08-16 | Nat Ct Geriatrics & Gerontology | membrane separation culture device and kit, method for separating stem cells, membrane separation, methods for producing membrane separation, modification, and for modifying the surface of a molded body |
RU2014140521A (en) | 2012-03-08 | 2016-04-27 | Новартис Аг | ADJUVANT COMPOSITIONS OF BOOSTER VACCINES |
AU2013311702A1 (en) | 2012-09-06 | 2015-02-19 | Novartis Ag | Combination vaccines with serogroup B meningococcus and D/T/P |
EP2906239A1 (en) | 2012-10-12 | 2015-08-19 | GlaxoSmithKline Biologicals SA | Non-cross-linked acellular pertussis antigens for use in combination vaccines |
CN105007935A (en) | 2012-12-18 | 2015-10-28 | 葛兰素史密丝克莱恩生物有限公司 | Conjugates for protecting against diphtheria and/or tetanus |
EP4144369A1 (en) | 2014-09-26 | 2023-03-08 | Seqirus UK Limited | Vaccination of immunocompromised subjects |
KR20170063750A (en) | 2014-09-26 | 2017-06-08 | 세퀴러스 유케이 리미티드 | Vaccination of immunocompromised subjects |
EP3226904B1 (en) | 2014-12-02 | 2019-03-06 | Novartis AG | Manufacture of surfactant-containing compositions |
EP3393481A1 (en) * | 2015-12-23 | 2018-10-31 | Novartis Ag | Oil-in-water emulsions including retinoic acid |
EP3917567A1 (en) | 2019-01-30 | 2021-12-08 | GlaxoSmithKline Biologicals SA | Oil/surfactant mixtures for self-emulsification |
EP4171514A1 (en) * | 2020-06-30 | 2023-05-03 | Seqirus UK Limited | Cold filtration of oil-in-water emulsion adjuvants |
CN113876943A (en) * | 2020-07-03 | 2022-01-04 | 神州细胞工程有限公司 | Concentrated oil-in-water type submicron emulsion adjuvant and preparation method thereof |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4060082A (en) | 1976-08-16 | 1977-11-29 | Mpl, Inc. | Dual-ingredient medication dispenser |
US4340482A (en) | 1978-02-21 | 1982-07-20 | Millipore Corporation | Process for grafting amino acid molecules onto preformed polymer surfaces and products prepared thereby |
US4198183A (en) | 1978-11-01 | 1980-04-15 | Claus Kowitz | Motion translation apparatus |
US4673504A (en) | 1980-10-27 | 1987-06-16 | Cuno Inc. | Charge modified microporous membrane |
US4473474A (en) | 1980-10-27 | 1984-09-25 | Amf Inc. | Charge modified microporous membrane, process for charge modifying said membrane and process for filtration of fluid |
US4533254A (en) | 1981-04-17 | 1985-08-06 | Biotechnology Development Corporation | Apparatus for forming emulsions |
US4432875A (en) | 1981-05-29 | 1984-02-21 | Brunswick Corporation | Semi-permeable membranes and processes for making the same |
US4473475A (en) | 1981-05-29 | 1984-09-25 | Amf Inc. | Charge modified microporous membrane, process for charge modifying said membrane, and process for filtration of fluids |
US4413074A (en) | 1982-01-25 | 1983-11-01 | Brunswick Corporation | Hydrophilic surfaces and process for making the same |
NZ209308A (en) | 1983-08-30 | 1991-08-27 | Genentech Inc | Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein |
US4705753A (en) | 1984-06-08 | 1987-11-10 | Gregor Harry P | Biologically active acrylonitrile-based copolymeric membrane |
US4618533A (en) | 1984-11-30 | 1986-10-21 | Millipore Corporation | Porous membrane having hydrophilic surface and process |
US4794002A (en) | 1985-11-01 | 1988-12-27 | Monsanto Company | Modified polymeric surfaces and process for preparing same |
US4964990A (en) | 1987-05-20 | 1990-10-23 | Gelman Sciences, Inc. | Filtration membranes and method of making the same |
US4943374A (en) | 1988-04-21 | 1990-07-24 | Gessner & Co., Gmbh | Use of a microporous membrane constructed of polyether sulfon and hydrophilization agent for the filtration of beer |
ATE175681T1 (en) | 1988-10-17 | 1999-01-15 | Hemasure Inc | METHOD FOR THE COVALENT SURFACE MODIFICATION OF HYDROPHOBIC POLYMERS AND PRODUCTS THEREOF |
CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
CA2086831C (en) | 1991-05-08 | 1999-03-16 | Reinhard Gluck | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
JPH0614756Y2 (en) | 1991-06-26 | 1994-04-20 | 株式会社アルテ | Assembled dual chamber syringe |
US5178765A (en) | 1991-09-18 | 1993-01-12 | Gelman Sciences Inc. | Hydrophilic membranes prepared from polyethersulfone/poly-2-oxazoline/polyvinylpyrrolidone blend |
US5496811A (en) | 1992-08-28 | 1996-03-05 | Pharmos Corp. | Submicron emulsions as ocular drug delivery vehicles |
US5277812A (en) | 1993-02-12 | 1994-01-11 | Gelman Sciences Inc. | Inter-penetrating network charge modified microporous membrane |
US5531893A (en) | 1993-02-12 | 1996-07-02 | Gelman Sciences Inc. | Inter-penetrating network charge modified microporous membrane |
US6645463B1 (en) | 1994-05-16 | 2003-11-11 | The Board Of Regents Of The University Of Michigan | Blood-pool selective carrier for lipophilic imaging agents |
DE69528062T2 (en) | 1994-06-20 | 2003-04-30 | Nippon Shinyaku Co Ltd | METHOD FOR PRODUCING EMULSIONS FROM AN EMULGATOR |
US5487965A (en) | 1994-09-06 | 1996-01-30 | Xerox Corporation | Processes for the preparation of developer compositions |
US5496284A (en) | 1994-09-27 | 1996-03-05 | Waldenburg; Ottfried | Dual-chamber syringe & method |
US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
DE19542499A1 (en) | 1995-11-15 | 1997-05-22 | Bayer Ag | Method and device for producing a parenteral drug preparation |
DE19612966B4 (en) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK cells and methods of propagating influenza viruses |
WO1998001174A1 (en) | 1996-07-05 | 1998-01-15 | Debiotech S.A. | Dual-chamber syringe for mixing two substances prior to injection |
US6168718B1 (en) * | 1996-11-08 | 2001-01-02 | Pall Corporation | Method for purifying blood plasma and apparatus suitable therefor |
EP0946250B1 (en) | 1996-11-12 | 2004-06-30 | Whatman Inc. | Hydrophilic polymeric phase inversion membrane |
US5971953A (en) | 1998-01-09 | 1999-10-26 | Bachynsky; Nicholas | Dual chamber syringe apparatus |
AU9785598A (en) | 1997-10-03 | 1999-04-27 | Texas Pharmaceuticals, Inc. | Improved dual chamber syringe apparatus |
US6039872A (en) | 1997-10-27 | 2000-03-21 | Pall Corporation | Hydrophilic membrane |
WO1999050189A1 (en) | 1998-03-30 | 1999-10-07 | Ebara Corporation | Method and device for treating manganese-containing water |
GB9808689D0 (en) | 1998-04-23 | 1998-06-24 | Kalsep Ltd | Improved membrane |
DE19835749C1 (en) | 1998-08-07 | 2000-02-03 | Dieter Perthes | Ready-to-use syringe for unstable drugs |
JP3995830B2 (en) | 1999-01-13 | 2007-10-24 | 富士フイルム株式会社 | Thermally developed image recording material |
US6193077B1 (en) | 1999-02-08 | 2001-02-27 | Osmonics, Inc. | Non-cracking hydrophilic polyethersulfone membranes |
ATE297190T1 (en) | 1999-02-26 | 2005-06-15 | Chiron Corp | MICROEMULSIONS WITH ADSORBED MACROMOLECULES AND MICROPARTICLES |
GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
DE10059430A1 (en) | 2000-11-30 | 2002-06-06 | Cognis Deutschland Gmbh | Finely divided emulsions |
TWI228420B (en) | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
WO2003063911A1 (en) * | 2002-02-01 | 2003-08-07 | Anges Mg, Inc. | Decoy-containing pharmaceutical compositions and method of using the same |
US20060148776A1 (en) * | 2003-03-13 | 2006-07-06 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
BRPI0408635B1 (en) | 2003-04-04 | 2019-07-16 | Zoetis Services Llc | METHOD FOR PREPARATION OF A MICROFLUIDIZED WATER OIL EMULSION IN THE SUBMICROMETER RANGE WITH A LOWER MEDIUM OIL GULIC SIZE AT 0.5? MICROFLUIDIZED VACCINE |
US20050208083A1 (en) | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
WO2005027872A2 (en) | 2003-06-04 | 2005-03-31 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
CN1933862A (en) | 2004-03-23 | 2007-03-21 | 尼普洛株式会社 | Pre-filled syringe |
WO2005089718A2 (en) | 2004-03-23 | 2005-09-29 | Novartis Ag | Pharmaceutical compositions |
JP5393978B2 (en) | 2004-04-05 | 2014-01-22 | ゾエティス・ピー・エルエルシー | Microfluidized oil-in-water emulsion and vaccine composition |
GB0411411D0 (en) | 2004-05-21 | 2004-06-23 | Glaxosmithkline Biolog Sa | Vaccines |
GB0416120D0 (en) * | 2004-07-19 | 2004-08-18 | Health Prot Agency | Stable compositions containing OMV's |
JP4778518B2 (en) * | 2004-10-13 | 2011-09-21 | スリーエム イノベーティブ プロパティーズ カンパニー | Preparation method of hydrophilic polyethersulfone membrane |
EP1809237B1 (en) | 2004-11-09 | 2008-12-31 | Novagali Pharma SA | Ophthalmic oil-in-water type emulsion with stable positive zeta potential |
GB0427568D0 (en) | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
PE20061428A1 (en) | 2005-03-23 | 2007-01-16 | Glaxosmithkline Biolog Sa | VACCINE FORMULATION INCLUDING AN OIL EMULSION ADJUVANT IN WATER AND 3D-MPL |
US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
EP1951200A2 (en) | 2005-08-09 | 2008-08-06 | Nanobio Corporation | Nanoemulsion compositions having anti-inflammatory activity |
DK1945271T3 (en) | 2005-10-24 | 2020-01-13 | Magsense Life Sciences Inc | Process for the preparation of polymer-coated microparticles |
NZ567978A (en) | 2005-11-04 | 2011-09-30 | Novartis Vaccines & Diagnostic | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
FR2896162B1 (en) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | EMULSION OIL IN THERMOREVERSIBLE WATER |
ES2619160T7 (en) * | 2006-01-27 | 2020-07-29 | Seqirus Uk Ltd | Flu vaccines containing hemagglutinin and matrix proteins |
WO2007098186A2 (en) | 2006-02-22 | 2007-08-30 | Novavax, Inc. | Adjuvant and vaccine compositions |
EP1849452A1 (en) | 2006-04-27 | 2007-10-31 | Cognis IP Management GmbH | Dispersions containing acylglutamate |
SI2043682T1 (en) | 2006-07-17 | 2014-07-31 | Glaxosmithkline Biologicals S.A. | Influenza vaccine |
GB0622282D0 (en) | 2006-11-08 | 2006-12-20 | Novartis Ag | Quality control methods |
SG177141A1 (en) | 2006-12-06 | 2012-01-30 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
WO2008076371A2 (en) * | 2006-12-15 | 2008-06-26 | Schering-Plough Ltd. | Method for replicating influenza virus in culture |
EP2262369A4 (en) * | 2008-04-04 | 2013-05-29 | Robert Shorr | Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents |
US8187554B2 (en) | 2008-04-23 | 2012-05-29 | Microfluidics International Corporation | Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems |
TW201006517A (en) * | 2008-05-22 | 2010-02-16 | Asahi Kasei Medical Co Ltd | Filtration method |
EP2307021A4 (en) * | 2008-06-19 | 2011-08-10 | Neurosystec Corp | Formulations |
DE102009056884B4 (en) | 2009-12-03 | 2021-03-18 | Novartis Ag | Vaccine Adjuvants and Improved Methods for Making Same |
DE102009056871A1 (en) | 2009-12-03 | 2011-06-22 | Novartis AG, 4056 | Vaccine adjuvants and improved methods of making the same |
CN105055311A (en) | 2009-12-03 | 2015-11-18 | 诺华股份有限公司 | Circulation of components during homogenization /microfluidisation of emulsions |
EP2506833B1 (en) | 2009-12-03 | 2014-04-16 | Novartis AG | Arranging interaction and back pressure chambers for microfluidization |
MX2012005598A (en) | 2009-12-03 | 2012-05-29 | Novartis Ag | Hydrophilic filtration during manufacture of vaccine adjuvants. |
GB201009671D0 (en) | 2010-06-10 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel process |
-
2010
- 2010-12-03 MX MX2012005598A patent/MX2012005598A/en active IP Right Grant
- 2010-12-03 PT PT102520442T patent/PT2343052E/en unknown
- 2010-12-03 PL PL10252044T patent/PL2343052T3/en unknown
- 2010-12-03 SI SI201031055T patent/SI2601933T1/en unknown
- 2010-12-03 KR KR1020127012098A patent/KR101616735B1/en active IP Right Grant
- 2010-12-03 SI SI201030614T patent/SI2506832T1/en unknown
- 2010-12-03 DK DK10252044.2T patent/DK2343052T3/en active
- 2010-12-03 WO PCT/IB2010/003273 patent/WO2011067669A2/en active Application Filing
- 2010-12-03 NZ NZ599881A patent/NZ599881A/en unknown
- 2010-12-03 ES ES13157613.4T patent/ES2558056T3/en active Active
- 2010-12-03 US US13/508,986 patent/US10213383B2/en active Active
- 2010-12-03 KR KR1020157008289A patent/KR101625623B1/en active IP Right Grant
- 2010-12-03 SG SG10201501612RA patent/SG10201501612RA/en unknown
- 2010-12-03 BR BR112012013425-6A patent/BR112012013425A2/en not_active Application Discontinuation
- 2010-12-03 CN CN201510144280.8A patent/CN104688687A/en active Pending
- 2010-12-03 EA EA201270519A patent/EA025622B1/en not_active IP Right Cessation
- 2010-12-03 ES ES10807661.3T patent/ES2461852T3/en active Active
- 2010-12-03 JP JP2012541594A patent/JP5754860B2/en active Active
- 2010-12-03 AU AU2010325748A patent/AU2010325748B2/en active Active
- 2010-12-03 EP EP13157613.4A patent/EP2601933B1/en not_active Revoked
- 2010-12-03 ES ES10252044T patent/ES2426969T3/en active Active
- 2010-12-03 CN CN201080056000.3A patent/CN102858322B/en active Active
- 2010-12-03 EP EP10807661.3A patent/EP2506832B1/en not_active Revoked
- 2010-12-03 CA CA2780425A patent/CA2780425C/en active Active
- 2010-12-03 EP EP10252044.2A patent/EP2343052B1/en not_active Revoked
-
2012
- 2012-01-13 HK HK12100448.4A patent/HK1159995A1/en not_active IP Right Cessation
- 2012-05-07 IL IL219627A patent/IL219627B/en active IP Right Grant
- 2012-05-15 CL CL2012001268A patent/CL2012001268A1/en unknown
-
2013
- 2013-03-06 HK HK13102772.5A patent/HK1175407A1/en not_active IP Right Cessation
- 2013-07-03 HR HRP20130623AT patent/HRP20130623T1/en unknown
-
2015
- 2015-03-03 JP JP2015040914A patent/JP2015098499A/en active Pending
-
2019
- 2019-01-03 US US16/238,625 patent/US10799454B2/en active Active
-
2020
- 2020-09-09 US US17/015,550 patent/US20210077395A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130623T1 (en) | Hydrophilic filtration during manufacture of vaccine adjuvants | |
IL254600A0 (en) | Pcsk9 vaccine | |
IL217008A0 (en) | Vaccine | |
EP2410855A4 (en) | Process for the preparation of alogliptin | |
GB0908193D0 (en) | Treatment of disease state | |
EP2408473A4 (en) | Vaccination methods | |
GB201006165D0 (en) | Vaccine | |
EP2482843A4 (en) | Methods of improving vaccine immunogenicity | |
IL216102A0 (en) | Combined measles-malaria vaccine | |
EP2522360A4 (en) | Vaccine for treatment of tautopathy | |
GB2467215B (en) | Burkholderia components vaccine | |
GB201204454D0 (en) | Methods of inducing tissue regeneration | |
EP2403507A4 (en) | Treatment of infection | |
IL217194A0 (en) | Vaccine | |
GB0913944D0 (en) | Treatment of diseases caused by viral infection | |
EP2459540A4 (en) | Preparation of fipamezole | |
IL215143A0 (en) | Process for the preparation of alogliptin | |
GB0919711D0 (en) | Treatment of viral infections | |
GB0913914D0 (en) | Treatment of viral infections | |
ZA201107971B (en) | Combined measles-malaria vaccine | |
GB0914545D0 (en) | Vaccine | |
GB0908666D0 (en) | Treatment of proteostatic disease | |
GB201003332D0 (en) | Efficient preparation of combination vaccines | |
GB0903910D0 (en) | Vaccine production |